Aristololactam I

CAS No. 13395-02-3

Aristololactam I( —— )

Catalog No. M17961 CAS No. 13395-02-3

Aristololactam I has cytotoxic potency, mediated through the induction of apoptosis in a caspase 3-dependent pathway.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 129 In Stock
10MG 205 In Stock
25MG 350 In Stock
50MG 516 In Stock
100MG 734 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Aristololactam I
  • Note
    Research use only, not for human use.
  • Brief Description
    Aristololactam I has cytotoxic potency, mediated through the induction of apoptosis in a caspase 3-dependent pathway.
  • Description
    Aristololactam I has cytotoxic potency, mediated through the induction of apoptosis in a caspase 3-dependent pathway. The effects of Aristololactam I may be mediated by different mechanisms except TGF-beta1 pathway. 3. Aristololactam I may be one of toxic metabolites in Chinese herbs containing AA which participate in renal damage and fibrosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    IL Receptor
  • Recptor
    Caspase-3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    13395-02-3
  • Formula Weight
    293.27
  • Molecular Formula
    C17H11NO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 12.5 mg/mL (42.62 mM)
  • SMILES
    COC1=CC=CC2=C3C4=C(C=C21)NC(=O)C4=CC5=C3OCO5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pranlukast

    Pranlukast is a cysteinyl leukotriene receptor-1 antagonist.

  • Nothofagin

    Nothofagin has antioxidant, and antithrombotic activities, it possesses anti-inflammatory activity by inhibiting hyperpermeability, expression of CAMs, and adhesion and migration of leukocytes, thereby endorsing its usefulness as a therapy for vascular inflammatory diseases.

  • PF-07038124 HCl

    PF-07038124 HCl is a selective and potent PDE4 inhibitor with an IC50 of 0.5 nM for PDE4B2.PF-07038124 HCl inhibits IL-13, IL-4, and IFNγ, and can be used in the study of skin disorders such as atopic dermatitis and plaque psoriasis.